148 related articles for article (PubMed ID: 1592338)
1. Absence of hepatitis B virus precore mutants in patients with chronic hepatitis B responding to interferon-alpha.
Xu J; Brown D; Harrison T; Lin Y; Dusheiko G
Hepatology; 1992 Jun; 15(6):1002-6. PubMed ID: 1592338
[TBL] [Abstract][Full Text] [Related]
2. Nucleotide sequence analysis of precore and proximal core regions in patients with chronic hepatitis B treated with interferon.
Laskus T; Rakela J; Persing DH
Dig Dis Sci; 1995 Jan; 40(1):1-7. PubMed ID: 7821093
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus precore/core variation and interferon therapy.
Fattovich G; McIntyre G; Thursz M; Colman K; Giuliano G; Alberti A; Thomas HC; Carman WF
Hepatology; 1995 Nov; 22(5):1355-62. PubMed ID: 7590647
[TBL] [Abstract][Full Text] [Related]
4. Association between frequency of amino acid changes in core region of hepatitis B virus (HBV) and the presence of precore mutation in Japanese HBV carriers.
Karasawa T; Shirasawa T; Okawa Y; Kuramoto A; Shimada N; Aizawa Y; Zeniya M; Toda G
J Gastroenterol; 1997 Oct; 32(5):611-22. PubMed ID: 9349986
[TBL] [Abstract][Full Text] [Related]
5. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.
Bozkaya H; Ayola B; Lok AS
Hepatology; 1996 Jul; 24(1):32-7. PubMed ID: 8707278
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus variants with core gene deletions in the evolution of chronic hepatitis B infection.
Marinos G; Torre F; Günther S; Thomas MG; Will H; Williams R; Naoumov NV
Gastroenterology; 1996 Jul; 111(1):183-92. PubMed ID: 8698197
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus precore mutants in HBeAg carriers with chronic hepatitis treated with interferon.
Lampertico P; Manzin A; Rumi MG; Paolucci S; Del Ninno E; Clementi M; Colombo M
J Viral Hepat; 1995; 2(5):251-6. PubMed ID: 8745317
[TBL] [Abstract][Full Text] [Related]
8. Mixed cryoglobulinemia type II in chronic hepatitis B associated with HBe-minus HBV mutant: cellular immune reactions and response to interferon treatment.
Löhr H; Goergen B; Weber W; Gödderz W; Meyer zum Büschenfelde KH; Gerken G
J Med Virol; 1994 Dec; 44(4):330-5. PubMed ID: 7897364
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus precore mutations and HBeAg negative reactivation of chronic hepatitis B after interferon therapy.
Talbodec N; Loriot MA; Gigou M; Guigonis V; Boyer N; Bezeaud A; Erlinger S; Benhamou JP; Marcellin P
Liver; 1995 Apr; 15(2):93-8. PubMed ID: 7540713
[TBL] [Abstract][Full Text] [Related]
10. Precore wild-type DNA and immune complexes persist in chronic hepatitis B after seroconversion: no association between genome conversion and seroconversion.
Maruyama T; Kuwata S; Koike K; Iino S; Yasuda K; Yotsuyanagi H; Moriya K; Maekawa H; Yamada H; Shibata Y; Milich DR
Hepatology; 1998 Jan; 27(1):245-53. PubMed ID: 9425944
[TBL] [Abstract][Full Text] [Related]
11. The two different states of hepatitis B virus DNA in asymptomatic carriers: HBe-antigen-positive versus anti-HBe-positive asymptomatic carriers.
Fujiwara K; Yokosuka O; Ehata T; Chuang WL; Imazeki F; Saisho H; Omata M
Dig Dis Sci; 1998 Feb; 43(2):368-76. PubMed ID: 9512133
[TBL] [Abstract][Full Text] [Related]
12. Conservation of precore and core sequences of hepatitis B virus in chronic viral carriers.
Hawkins AE; Gilson RJ; Bickerton EA; Tedder RS; Weller IV
J Med Virol; 1994 May; 43(1):5-12. PubMed ID: 8083648
[TBL] [Abstract][Full Text] [Related]
13. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
[TBL] [Abstract][Full Text] [Related]
14. The impact of hepatitis B virus precore/core gene carboxyl terminal mutations on viral biosynthesis and the host immune response.
Wu JF; Ni YH; Chen HL; Hsu HY; Chang MH
J Infect Dis; 2014 May; 209(9):1374-81. PubMed ID: 24273041
[TBL] [Abstract][Full Text] [Related]
15. Core promoter mutations of hepatitis B virus for the response to interferon in e antigen-positive chronic hepatitis B.
Kanai K; Kako M; Aikawa T; Hino K; Tsubouchi H; Takehira Y; Iwabuchi S; Kawasaki T; Tsuda F; Okamoto H; Miyakawa Y; Mayumi M
Am J Gastroenterol; 1996 Oct; 91(10):2150-6. PubMed ID: 8855739
[TBL] [Abstract][Full Text] [Related]
16. Low-dose recombinant interferon therapy in anti-HBe-positive chronic hepatitis B in Asian Indians.
Guptan RC; Thakur V; Malhotra V; Sarin SK
J Gastroenterol Hepatol; 1998 Jul; 13(7):675-9. PubMed ID: 9715416
[TBL] [Abstract][Full Text] [Related]
17. Genetic heterogeneity in the precore region of hepatitis B virus in hepatitis B e antigen-negative chronic hepatitis B patients: spontaneous seroconversion and interferon-induced seroconversion.
Karasawa T; Aizawa Y; Zeniya M; Kuramoto A; Shirasawa T; Toda G
J Med Virol; 1995 Apr; 45(4):373-80. PubMed ID: 7666040
[TBL] [Abstract][Full Text] [Related]
18. Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States.
Laskus T; Persing DH; Nowicki MJ; Mosley JW; Rakela J
Gastroenterology; 1993 Oct; 105(4):1173-8. PubMed ID: 8405863
[TBL] [Abstract][Full Text] [Related]
19. Comparison of envelope and precore/core variants of hepatitis B virus (HBV) during chronic HBV infection.
Takayanagi M; Kakumu S; Ishikawa T; Higashi Y; Yoshioka K; Wakita T
Virology; 1993 Sep; 196(1):138-45. PubMed ID: 8356791
[TBL] [Abstract][Full Text] [Related]
20. Low HBeAg serum levels correlate with the presence of the double A1762T/G1764A core promoter mutation and a positive response to interferon in patients with chronic hepatitis B virus infection.
Marrone A; Zampino R; Luongo G; Utili R; Karayiannis P; Ruggiero G
Intervirology; 2003; 46(4):222-6. PubMed ID: 12931030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
